???pagination.result.count???
???pagination.result.page???
1
Targeting cell-bound MUC1 on myelomonocytic, monocytic leukemias and phenotypically defined leukemic stem cells with anti-SEA module antibodies. , Guillaume T, Dehame V, Chevallier P, Peterlin P, Garnier A, Grégoire M, Pichinuk E, Rubinstein DB, Wreschner DH., Exp Hematol. February 1, 2019; 70 97-108.
''Click cyclic ADP-ribose'': a neutral second messenger mimic. , Swarbrick JM, Graeff R, Garnham C, Thomas MP, Galione A , Potter BV., Chem Commun (Camb). March 7, 2014; 50 (19): 2458-61.
Determination of ADP-ribosyl cyclase activity, cyclic ADP-ribose, and nicotinic acid adenine dinucleotide phosphate in tissue extracts. , Graeff RM, Lee HC., Methods Mol Biol. January 1, 2013; 1016 39-56.
Ca(2+) signaling occurs via second messenger release from intraorganelle synthesis sites. , Davis LC, Morgan AJ, Ruas M, Wong JL, Graeff RM, Poustka AJ, Lee HC, Wessel GM , Parrington J, Galione A ., Curr Biol. October 28, 2008; 18 (20): 1612-8.
Signaling properties of CD38 in the mouse immune system: enzyme-dependent and -independent roles in immunity. , Lund FE., Mol Med. January 1, 2006; 12 (11-12): 328-33.
Metabolism of cyclic ADP-ribose: Zinc is an endogenous modulator of the cyclase/NAD glycohydrolase ratio of a CD38-like enzyme from human seminal fluid. , Zielinska W, Barata H, Chini EN., Life Sci. February 20, 2004; 74 (14): 1781-90.
Total synthesis of cyclic ADP-carbocyclic-ribose, a stable mimic of Ca2+-mobilizing second messenger cyclic ADP-ribose. , Shuto S, Fukuoka M, Manikowsky A, Ueno Y, Nakano T, Kuroda R, Kuroda H, Matsuda A., J Am Chem Soc. September 12, 2001; 123 (36): 8750-9.
Cyclic ADP-ribose. , Guse AH., J Mol Med (Berl). January 1, 2000; 78 (1): 26-35.
Cyclic 3-deaza-adenosine diphosphoribose: a potent and stable analog of cyclic ADP-ribose. , Wong L, Aarhus R, Lee HC, Walseth TF., Biochim Biophys Acta. November 16, 1999; 1472 (3): 555-64.
Probing Aplysia californica adenosine 5''-diphosphate ribosyl cyclase for substrate binding requirements: design of potent inhibitors. , Migaud ME, Pederick RL, Bailey VC, Potter BV., Biochemistry. July 13, 1999; 38 (28): 9105-14.
The CD38/cyclic ADP-ribose system: a topological paradox. , De Flora A, Guida L, Franco L, Zocchi E., Int J Biochem Cell Biol. October 1, 1997; 29 (10): 1149-66.
CD38 and ADP-ribosyl cyclase catalyze the synthesis of a dimeric ADP-ribose that potentiates the calcium-mobilizing activity of cyclic ADP-ribose. , De Flora A, Guida L, Franco L, Zocchi E, Bruzzone S, Benatti U, Damonte G, Lee HC., J Biol Chem. May 16, 1997; 272 (20): 12945-51.
Modulator and messenger functions of cyclic ADP-ribose in calcium signaling. , Lee HC., Recent Prog Horm Res. January 1, 1996; 51 355-88; discussion 389.
Enzymatic synthesis and characterizations of cyclic GDP-ribose. A procedure for distinguishing enzymes with ADP-ribosyl cyclase activity. , Graeff RM, Walseth TF, Fryxell K, Branton WD, Lee HC., J Biol Chem. December 2, 1994; 269 (48): 30260-7.
Human lymphocyte antigen CD38 catalyzes the production of cyclic ADP-ribose. , Summerhill RJ, Jackson DG, Galione A ., FEBS Lett. December 6, 1993; 335 (2): 231-3.